Simulations Plus to Participate in the BTIG Digital Health Forum
Simulations Plus, Inc. (NASDAQ: SLP) was upgraded by analysts at Stephens to a "strong-buy" rating.
Simulations Plus, Inc. (NASDAQ: SLP) is now covered by analysts at Stephens. They set an "overweight" rating and a $39.00 price target on the stock.
Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables
How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52% [Yahoo! Finance]